Home/Integrations/EHR/Osmind
For interventional psychiatry practices using OsmindThe Authorization Came Through. Why Didn't the Claim?
Interventional psychiatry bills in pieces: the drug, the administration, the monitoring period, the professional service. Any one of them can fail while the others pay, and a partly paid claim rarely gets a second look. Keep Osmind. Find out which piece is failing.
Start with the free CareVixis practice assessment. No email required.
The Authorisation Came Through.
The payer agreed to the treatment, the patient was scheduled, and the care was delivered as approved.
Authorisation Is One Piece of Several.
The claim also carries the drug, the administration, the monitoring time and the site of service, and each piece has its own rules that have to agree with the others.
So an Approved Treatment Still Goes Unpaid.
The denial is not about whether the treatment was allowed. It is about one component of how it was billed, which is a much harder thing to see from the outside.
Practices often appeal the authorisation, which was never the problem.
We Take the Claim Apart.
CareVixis identifies which component of the claim actually failed, records the denial reason against it, and reports the pattern, so the next claim for the same treatment does not repeat it.
Keep Osmind.
Osmind was built for practices doing exactly this work. Keeping it is a supported outcome, not a fallback, and only the billing follow-up changes hands.
Keep Osmind. Find out which piece of the claim is failing.
Everything below is the evidence for what you just read.
What Osmind publishes about its own platform, the six ways one treatment becomes a revenue problem, a ten-question framework you can put to any billing company, and the source for every fact on this page. If you have what you came for, you can stop here.
Why does an approved authorization still end in a denied claim?
Because the authorization approves the treatment, not the claim. The claim still has to agree with it on dates, units, site of service, the rendering provider and the codes actually billed. Approval is permission; payment is a separate test.
That gap is wider in interventional psychiatry than in routine outpatient work, because one encounter becomes several billable elements. Partial payment is normal here, which is precisely why an underpaid element can repeat for months without anyone noticing: the claim did not fail, so nothing flagged it.
Osmind Was Built for Exactly This Practice
Very few platforms are designed around in-clinic psychiatric treatment. Everything below is Osmind's own published description of its product.[1]
| What it does | How Osmind describes it |
|---|---|
| Built for the modality | "EHR, billing, prior auth, and patient engagement" built for "Spravato, TMS, ketamine, and other treatments redefining psychiatry". |
| Launching modalities | "Compliance automations, operational playbooks, direct manufacturer relationships, and payer contracts" for practices adding treatment types. |
| Billing tooling | "Built-in automation handles copays and intake workflows", with benefit verification, prior auth and denial detection available to practices "ready for more". |
| Charting | Charting templates, measurement-based care and compliance automations. |
| Network | Osmind describes a network of independent psychiatry practices with shared purchasing power and negotiated rates. |
If you are running Spravato or TMS on a general psychiatry EHR, that is the harder problem and this page is not it. This page is for practices whose software already fits, and whose revenue still does not add up.
Six Ways One Treatment Becomes a Revenue Problem
Each of these produces a different failure, and several of them produce a payment rather than a denial, which is worse, because nothing in the process asks about a claim that paid.
The authorization does not match what happened
Approved units, approved dates and the approved site are all conditions. Treatment schedules move; authorizations do not move with them.
The drug and the service are separate claims problems
Where a practice supplies the medication itself, the product and its administration are billed as different elements with different rules. One can pay while the other does not.
Monitoring time is a billable element, or it is lost
Treatments requiring an in-clinic observation period consume chair time and staff time. If that element is not billed, or is billed in the wrong units, the cost stays and the revenue does not.
Treatment courses outrun their approval
A TMS course or a maintenance schedule runs across weeks. Re-authorisation, session counts and continued-care criteria all have to keep pace, retroactively if they slip.
Site of service and supervision
Who administered, who supervised, and where, are payer questions with payer-specific answers. The denial that follows rarely names the real issue.
The cash-pay boundary moves quietly
When some treatment is self-pay by policy and some by resignation, the line drifts. Practices frequently cannot say how much billable treatment was written off because a claim was assumed to fail.
This is the argument for root cause analysis in one paragraph. Six different causes, several of which present as a payment rather than a denial. A reason code cannot tell them apart, and reworking the claim answers none of them.
Where This Fits Around What You Already Run
An illustration of the general flow for a practice keeping Osmind, not a description of any specific configuration.
- OsmindBenefits are verified, authorization is pursued, treatment is delivered and documented, the claim is produced.
- Clearinghouse and payerThe claim is adjudicated, in whole or in part.
- The remittance comes backPayment, adjustment, denial and patient responsibility, element by element, with the payer's reason codes.
- VixisIQ™Where appropriate data can be obtained and normalized, the remittance information is analyzed for patterns by payer, treatment type, element and time.
- VixisTrace™A problem claim is investigated for a root cause: which of the six it was, including the ones that paid.
- Corrective action, with an ownerWhat was done, by whom, by when, and recurrence monitored so you can tell whether it worked.
How Should You Evaluate a Billing Partner for an Interventional Practice?
Nine questions. Ask them of whoever bills for you now, of Osmind's own services, and of CareVixis. The value is in comparing the answers.
-
Have they billed this modality before, specifically?
Not psychiatry. The treatment you actually deliver, with the drug, administration and monitoring elements it involves.
-
Who owns authorization, and who notices when it drifts?
Ask what happens when a treatment schedule changes after approval, and who reconciles approved units against delivered units.
-
Do they check partly paid claims, or only denied ones?
This is the question for an interventional practice. A queue built on denials never sees an underpaid element.
-
Are payments checked against the contracted rate?
Ask how they would know if a payer had quietly changed what it pays for an administration code.
-
What happens the third time the same denial arrives?
Ask them to describe a root cause they found, what changed, and how they knew it worked.
-
Who tracks the self-pay boundary?
Ask who decides that a treatment is not worth billing, and whether anyone reviews that decision later.
-
Will they work inside Osmind?
Ask what they need from it and what changes if you keep it. CareVixis treats keeping Osmind as a supported outcome.
-
What will you see without asking?
Then the harder version: what would have told you a treatment element had been underpaid for three months?
-
Is the work performed in the United States?
Ask about subcontractors as well as staff. CareVixis is 100% US based and does not outsource.
Using Osmind? Keep It.
Osmind is built around the treatments you deliver, and very little else is. CareVixis has no interest in moving you off a platform that fits your clinical model, and a migration would answer none of the questions on this page.
Keeping your system is a supported outcome, not a fallback. If you later want to move to the CareVixis platform, that move may be offered at no additional migration charge. Keeping the EHR you already have carries no monthly software fee from CareVixis.
Keep Osmind. Find out which piece of the claim is failing.
Questions Interventional Psychiatry Practices Ask
Do I have to leave Osmind to work with CareVixis?
No. Keeping Osmind is a supported outcome, not a fallback. CareVixis claims no API integration, certification or partnership with Osmind, and what is agreed before any commitment is which revenue-cycle data can be obtained and how.
What makes interventional psychiatry billing different?
A routine psychiatry visit is largely one claim line. An in-clinic treatment can involve the drug, its administration, a monitoring period, and the professional service, each with its own coverage rules, units and documentation expectations. Partial payment is normal, which is exactly why underpayment goes unnoticed.
Osmind already offers billing services and prior authorization tools. What does CareVixis add?
A practice happy with its current arrangement should keep it. CareVixis is a revenue management company rather than a service attached to the software, and the specific addition is root cause analysis on individual failed claims plus pattern analysis across them, so a repeating cause becomes visible rather than being reworked every month.
We are partly cash pay. Does this still apply?
It applies to the insured part, and the mix itself is worth analyzing. Practices running both often cannot say what proportion of billable treatment is being written off to self-pay because a claim was expected to fail, which is a revenue decision being made by default rather than deliberately.
Does CareVixis give clinical or regulatory advice on these treatments?
No. Coverage, safety programme and administration requirements are set by the payer, the manufacturer and the regulator, and your clinical and compliance decisions are yours. CareVixis works on the revenue cycle: what was billed, what came back, and why.
Keep Osmind. Add Revenue Intelligence.
Keep your EHR. Keep your clearinghouse. Change what happens after the data comes back.
Free. No obligation. No email required.
Sources
- Osmind, product overview. Source of the quoted descriptions of an "EHR, billing, prior auth, and patient engagement" built for "Spravato, TMS, ketamine, and other treatments redefining psychiatry"; of "compliance automations, operational playbooks, direct manufacturer relationships, and payer contracts"; and of built-in automation for copays and intake with benefit verification, prior auth and denial detection. osmind.org. Accessed 18 September 2026. These are Osmind's own published descriptions of its product. CareVixis has not independently tested them and makes no claim about them.
- Centers for Medicare & Medicaid Services, Transactions (HIPAA Administrative Simplification), for the remittance advice standard referenced above. cms.gov. Accessed 18 September 2026.
Osmind publishes network and performance figures of its own. None is repeated here: CareVixis does not restate another company's marketing figures, and publishes no denial rate, recovery rate or revenue increase figure of its own. Nothing on this page describes coverage, safety programme or administration requirements for any treatment; those come from the payer, the manufacturer and the regulator.
Trademarks and non-affiliation
Osmind® is a trademark of its respective owner, and Spravato® is a trademark of its respective owner. Both are used here descriptively, to identify software a practice may use and treatments a practice may deliver. Quoted product descriptions are Osmind's own words, cited above.
CareVixis is not affiliated with, endorsed by, sponsored by or certified by Osmind or by any treatment manufacturer. No API integration, native integration, certification or partnership with Osmind is claimed.
Keep the EHR. Add Revenue Visibility Around It.
CareVixis supports practices that want to keep this EHR. VixisIQ™ adds revenue intelligence and VixisTrace™ supports claim root-cause work around the revenue cycle. If a practice later chooses CareVixis-owned technology, the Vixis products can work natively together, but migration is not required.